• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Randomized Clinical Trials & Placebo: Can You Trust the Drugs are Working & Safe?

Randomized Clinical Trials & Placebo: Can You Trust the Drugs are Working & Safe?

9781614700678
844.14 zł
759.72 zł Save 84.42 zł Tax included
Lowest price within 30 days before promotion: 759.72 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Randomised clinical trials (RCT) have been accepted as the golden standard of testing, which in turn makes chemical medicine evidence based. RCT is based on four assumptions:: the placebo effect is represented by a placebo pill; it is possible to make a double-blind test with biologically active drugs; beneficial and harmful effects of drugs are fairly measured in RCTs and an appropriate time frame for the test is used. RCTs can turn drugs that are only toxic and not beneficial at all into products sold as useful chemical medicine. Many pharmaceutical drugs on the market today are tested only with this flawed RTC-procedure and we recommend that these drugs be tested again using a rational method. This book presents new research which examines the helpfulness of drugs and the need for clinical trials in order to test whether it is safe to use these drugs or if a return to holistic medicine is necessary.
Product Details
73337
9781614700678
9781614700678

Data sheet

Publication date
2012
Issue number
1
Cover
hard cover
Dimensions (mm)
260.00 x 180.00
Weight (g)
532
  • Introduction; The errors & deficiencies of the randomised, clinical trial (RCT); Problems with the premises of the RCT:: The placebo pill has no placebo effect at all so the drugs win the race; Passive or active placebo; Measuring the effect of drugs in RTC. Shall documentation be based on disease markers, local symptoms, or global dimensions of self-rated health, quality of life, & ability?; The observation time of the randomised clinical trial (RCT); Efficacy of biomedicine in general practice:: Why only one patient in a hundred gets help; The cost of a patient cured with biomedicine compared to the original, Hippocratic, holistic medicine; The chemical medicines efficacy in the serious diseases. Somatic medicine:: Cancer & coronary heart disease. Psychiatry:: Depression & schizophrenia.; The marketing strategy, the values, & the people of Big Pharma; Biomedicine & Holistic Medicine in conflict; How do we develop medicine from being poisonous drugs into being an efficient & safe medicine?; Conclusion:: The pharmaceutical industry sells poisons as medicine & knows that the documentation should be better; Scientific résumé.
Comments (0)